Direct-acting antiviral regimens and telemedicine services are both options for treating hepatitis C virus within the prison setting. A study compared factors associated with HCV treatment success over the past decade in Israeli prisons and concluded that screening this high-risk population and using telemedicine for treatment may be an effective strategy for the elimination of HCV from the prison population.

Educational Objectives

• Evaluate the impact of direct-acting antiviral regimens on the success of HCV treatment among incarcerated individuals
• Examine how the implementation of telemedicine contributed to an increase in the number of individuals receiving treatment
• Discuss the importance of targeted screening programs in mitigating HCV transmission and reducing disease burden

Level:Intermediate